Radiological intervention to maintain vascular access.
Stenoses and thromboses of dialysis grafts and fistulae are common problems in patients with end stage renal disease (ESRD). Timely recognition and treatment of access-related complications are essential to achieve long-term access function. Minimally invasive percutaneous interventions are techniques of growing importance for the interventional community. While stenoses can typically be treated by balloon angioplasty (PTA), thrombotic lesions may necessitate the combination of mechanical devices and/or thrombolytic agents with ancillary PTA. In this article, interventional treatments for the failing arteriovenous (AV) access are presented and reviewed.
Haage
P
P
Department of Diagnostic Radiology, RWTH Aachen University, Pauwelsstrasse 30, D-52057 Aachen, Germany. phaage@wuppertal.helios-kliniken.de
Günther
R W
RW
D000800:Angioplasty, Balloon; D001166:Arteriovenous Shunt, Surgical; D019917:Blood Vessel Prosthesis Implantation; D002405:Catheterization, Central Venous; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003251:Constriction, Pathologic / Q000000981:diagnostic imaging* / Q000628:therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging* / Q000628:therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000000981:diagnostic imaging* / Q000628:therapy; D011859:Radiography; D006435:Renal Dialysis; D015607:Stents; D013927:Thrombosis / Q000000981:diagnostic imaging* / Q000628:therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use; D014654:Vascular Patency
D005343:Fibrinolytic Agents; D014568:Urokinase-Type Plasminogen Activator